News

Fortive Corporation Adjusts Forecast Despite Earnings Surges

Fortive Corporation Adjusts Forecast Despite Earnings Surges

Fortive Corporation Adjusts Price Target While Retaining Buy Rating

Recently, Truist Securities revised its outlook on Fortive Corporation (NYSE: FTV), lowering the price target to $89 from $90 but keeping a Buy rating intact. This adjustment follows a 3% decline in Fortive’s stock, which contrasted with a stable S&P 500.

Despite the stock slip, Fortive surprised everyone with its third-quarter adjusted earnings per share (EPS) exceeding predictions. This positive performance stemmed from beneficial tax conditions, although it faced challenges due to rising corporate expenses affecting adjusted operating income.

Fortive has also re-evaluated its full-year 2024 adjusted EPS guidance. The company now anticipates a modest increase of about $0.03 at the midpoint, adjusting the range to $3.84 to $3.87, centering at $3.86.

This forecast reflects a decreased full-year tax rate estimate of approximately 11%, down from earlier projections of about 12%. However, Fortive has revised its sales outlook downward, now expecting core growth around 1%, compared to an earlier forecast of 2-3%.

A standout performer within the company has been the Advanced Health & Sustainability Solutions (AHS) segment. This division achieved impressive organic growth of 9% and saw a significant 310 basis point increase in operating margins year-over-year. AHS has also updated its overall guidance, now predicting core growth in the mid to high-single digits, improved from the previous mid-single-digit forecast.

Looking at margins, AHS is forecasting a remarkable rise of 200 basis points year-over-year to approximately 26.2%, outperforming earlier expectations of around 25.7%.

Conversely, the Intelligent Operating Solutions (IOS) segment faced challenges due to customer delays affecting its Fluke and FAL businesses, resulting in a core growth rate of 2%. As a result, Fortive has tempered its core growth predictions for IOS from mid to low-single digits, yet it remains optimistic about achieving a 100 basis point margin improvement over the course of the year.

The Product Realization (PT) segment displayed mixed outcomes; core growth has decreased by 4% while margins saw a 70 basis point improvement. Regardless, core growth guidance and margins for PT stay unchanged, highlighted by a notable increase in Tektronix orders in the high-single digits, and double-digit growth in Aerospace & Defense sectors, alongside improved sensing orders.

As we look towards fiscal year 2025, the guidance holds paramount importance, especially with the anticipated spin-off scheduled for the fourth quarter of that year. The former target of $4.50 has been reassessed based on the 2024 baseline. Nonetheless, Fortive's free cash flow continues to surpass expectations, underlining the company’s commitment to focused share buybacks.

Post-buyback, Fortive plans a more balanced strategy regarding acquisitions and returning cash to shareholders for the remaining company. The anticipated timing of the PT spin-off aligns with a predicted rise in industrial organic growth.

In recent developments, Fortive reported robust performance in its third quarter, showcasing a notable 14% rise in adjusted EPS and a 12% increase in free cash flow, highlighting the company’s strength.

This robust performance emanated from growth in both AHS and IOS segments, which significantly contributed to record adjusted gross and operating margins. Fortive continues to progress with its plans to spin off the Precision Technologies segment, having repurchased approximately 4 million shares in Q3.

The outlook remains optimistic, with expectations of continued growth in recurring revenue and gradual recovery within Precision Technologies, despite facing potential geopolitical and economic challenges. Guidance for the fourth quarter anticipates 3% revenue growth alongside adjusted EPS in the range of $1.11 to $1.14. The full-year adjusted diluted EPS expects to increase to between $3.84 and $3.87, indicating a healthy year-over-year rise of 12% to 13%.

Analysts foresee sustained momentum in recurring revenue and a gradual recovery for 2025, bolstered by operational execution and productivity measures.

Notably, challenges such as potential increases in tax rates and broader economic uncertainties could impact EPS growth in 2025. Investors are advised to stay tuned to Fortive's developments and overall performance.

InvestingPro Insights

To further enhance the understanding of Fortive's recent performance and future outlook, insights from InvestingPro provide valuable information. Currently, Fortive's market capitalization stands at approximately $24.78 billion, with a P/E ratio of 29.83, suggesting a relatively high valuation in light of its near-term earnings growth potential.

One key insight from InvestingPro highlights Fortive's impressive gross profit margins, reporting a gross profit margin of 59.74% over the last twelve months as of Q3 2024, supporting the reported gains in the AHS segment.

Additionally, Fortive operates with a moderate debt level, which may offer comfort to investors considering the company's strategic future plans and the potential spin-off mentioned. Analysts project profitability for the year, further endorsing a positive outlook despite adjustments to growth expectations.

Frequently Asked Questions

What is Fortive Corporation's current price target?

Truist Securities lowered the price target for Fortive Corporation to $89 while retaining a Buy rating.

How did Fortive's segments perform in the latest quarter?

The Advanced Health & Sustainability Solutions segment showed strong performance with 9% organic growth, while the Intelligent Operating Solutions segment faced delays, yielding only 2% core growth.

What are Fortive's EPS projections?

Fortive projects full-year adjusted diluted EPS to rise to between $3.84 and $3.87, demonstrating a robust year-over-year increase of 12% to 13%.

When is the planned spin-off for Fortive's Precision Technologies segment?

The planned spin-off for the Precision Technologies segment is scheduled for the fourth quarter of 2025.

What key insights were provided by InvestingPro?

InvestingPro noted Fortive's strong market capitalization and P/E ratio, along with impressive gross profit margins, and a moderate debt profile, supporting a positive outlook for the company.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Beemo, Choreo Forge AI Partnership for Wealth Management

Updated Category News Views 9

AI's New Role in Wealth Management Just when you think you've seen it all, along comes a partnership that shakes things up. Beemo Automation is teaming up with Choreo, a heavyweight in the tax-focused registered investment adviser world, to infuse some AI prowess where it matters. Choreographing their moves, they're looking to build something that's not just functional...

Continue Reading
Saudi Arabia Unveils CEER's Flagship Electric Vehicles

Updated Category News Views 4

CEER's Ambitious Leap in Automotive Innovation There's a new kid on the automotive block, and it's making some serious noise. Straight out of Jeddah, CEER has just taken the wraps off their flagship electric sedan and SUV, dubbed the EXOBOT. No small beans here—this is a full-throttle, Saudi-driven pitch into the global automotive circus. And why not? There's oil in...

Continue Reading
ViewScan Unveils New AI Solution and Enhanced Site

Updated Category News Views 3

ViewScan's Latest Step in AI-Powered Monitoring Long Island's own ViewScan just kicked up some dust in the AI-based monitoring scene. This outfit is rolling out a new release of its ViewScan Protect software, fortified with advanced analytics aimed at beefing up security and operational efficiency. Now, before you gloss over this news as just another tech update, let me...

Continue Reading
iFranchise Holds Top Spot in Consulting for 8 Years

Updated Category News Views 4

iFranchise's Unyielding Dominance in Franchise Consulting Five seconds in the franchise game, and you'd know that staying on top is a grind. But when you're iFranchise Group, it seems like the eighth time is the charm—if there ever was a need for luck. These folks have secured the number one spot in Entrepreneur magazine's Top Franchise Suppliers ranking yet again....

Continue Reading
Holland America Overhauls Half Moon Cay Offerings

Updated Category News Views 4

A Fresh Chapter for Half Moon Cay Mark it down, folks—Holland America Line is shaking things up over at RelaxAway, Half Moon Cay. The cruise line, known for its deep roots in premium cruising, is pouring resources into its private island playground to celebrate its 30th anniversary in 2027. And the timing couldn't be more calculated, what with peak cruise season around...

Continue Reading
ScriptSafe Revolutionizes Pharmacy Payment & Ad Certification

Updated Category News Views 4

Pharmacy Certification Made Easy When ScriptSafe rolled out its certification service for pharmacies, it felt like the industry's straitjacket was finally coming off. We’re talking about a process that traditionally took months, cost a small fortune, and made pharmacies fill out forms like they were honing a doctoral thesis. But now, you've got ScriptSafe offering a...

Continue Reading
Aranscia Joins Northside Hospital in Precision Oncology

Updated Category News Views 6

Unifying Molecular Diagnostics for Better Cancer Care In the chaos of today’s healthcare, Aranscia is aiming to rewrite the book on how we handle cancer diagnostics by teaming up with Northside Hospital Cancer Institute. Now, instead of fumbling through disconnected systems, they plan to glue the pieces together with a blend of their own and borrowed tech. This...

Continue Reading
Matchi Debuts Protein-Packed Matcha Lattes in Cans

Updated Category News Views 4

A New Twist on Protein Beverages Today, Matchi Global LLC is rolling out something new and bold: canned protein matcha lattes. It's not just another protein shake disguised in green robes. Oh no, this is a straight-up attempt to mesh pure ceremonial-grade matcha with a full 20 grams of complete filtered milk protein. And they’re delivering it all without any of those...

Continue Reading
GRAI's Innovative Play with Hangout FM in Streaming

Updated Category News Views 4

Reimagining Streaming: GRAI Buys Hangout FM The music streaming game has just been dealt a fresh hand. GRAI, an AI-driven music company, has snatched up Hangout FM, looking to ignite a social revolution in how we experience music. Sitting here, I'm thinking about all those playlists we've built but never truly shared. This acquisition might just change that by combining...

Continue Reading
Dr. Sarah Leary Leads CBTN's Growth in Pediatric Oncology

Updated Category News Views 3

Pioneering Leadership for Children's Brain Tumor Network In a world where every advance in pediatric oncology can make a measurable difference, the Children's Brain Tumor Network (CBTN) has just unveiled quite the ace up its sleeve: Dr. Sarah Leary. She's stepping in as Co-Chair of its Executive Board, taking the reins alongside Brian Rood, MD. With extensive experience...

Continue Reading

Top 5 Most Recently Viewed Articles

Pfizer Inc. Faces Investigation into Board's Responsibilities

Updated Category News Views 137

Investigating Pfizer Inc.'s Board of Directors PHILADELPHIA — An investigation is underway focused on the Board of Directors of Pfizer Inc. (NYSE: PFE). This arises from concerns regarding potential breaches of fiduciary duties in relation to the marketing and sale practices of Depo-Provera, a well-known injectable form of contraception as well as a treatment for...

Continue Reading
Exciting Updates on DISC-0974 for Chronic Kidney Disease Patients

Updated Category News Views 77

Overview of DISC-0974 Presentation Disc Medicine, Inc., a pioneering biopharmaceutical company, has made significant strides in the development of innovative treatments for hematologic diseases. They recently announced that new clinical data will be showcased at the upcoming American Society of Nephrology (ASN) Kidney Week, highlighting the promising drug DISC-0974....

Continue Reading
Semler Scientific (NASDAQ: SMLR) Financial Results and Strategy Overview

Updated Category News Views 154

Semler Scientific Plans Future Growth and Financial Position In an exciting new phase for Semler Scientific, Inc. (NASDAQ: SMLR), the company is navigating significant changes in the financial landscape. Semler Scientific, a trailblazer in medical devices and software designed to address chronic diseases, is preparing to share its third quarter financial results. However,...

Continue Reading
Transforming Marketing with RAD Intel's Innovative Insights

Updated Category News Views 46

Introduction to RAD Intel's New Functionality In the fast-paced world of digital marketing, staying ahead of the curve is paramount. RAD Intel has recently enhanced its platform by introducing state-by-state functionality, which offers brands and agencies precise localized marketing insights. This new feature is designed to empower marketers with detailed data that helps...

Continue Reading
Navigating the Complex Landscape of Datavault AI and IBM

Updated Category News Views 181

Understanding Datavault AI’s Current Position Datavault AI Inc (NASDAQ: DVLT) recently encountered a bearish technical signal while simultaneously experiencing a surge in business momentum. This juxtaposition raises questions about the future trajectory of the company. Despite hitting a recent death cross in stock trading—an indicator typically seen as a sign of...

Continue Reading